PATENT CLAIM ANALYSIS

Application Number: 15880303
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["435", "007100"]

Abstract:
The present invention provides methods for identifying biomarkers of disease capable of affecting cognitive function. The biomarkers identified by the methods of the prevention may be used for predicting whether a mammal will develop a disease capable of affecting cognitive function. More specifically, the present invention relates to the identification of biomarkers predictive of neurological diseases in a mammal and the use of these biomarkers in the diagnosis, differential diagnosis, and/or prognosis of the neurological disease. The methods and systems provided enable an assessment and theoretical prediction of neocortical amyloid loading based on the measurement of biomarkers that will provide an indication of whether a mammal is likely to develop a neurological disease.

Claim (Index 42):
The kit according to  claim 41  wherein the first component is a heparin sepharose column.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 86.0
- Lexical Diversity: 1.90476
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11910721', '15505317', '11911962', '15640545', '10982545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6221355183199985
- 35 USC 102 Novelty (BERT): 0.5205410281697567
- Combined Prediction Score: 0.6119760693049743
- Mean Citation Score: 253.206834
- Max Citation Score: 271.75677
- Similarity Product: 140.63971223775033

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test